Focus: Ergomed is a UK-based CRO with 501-1000 employees headquartered in Guildford, operating across clinical trial management, pharmacovigilance, and regulatory services. The company manages a diverse pipeline of 14 programs across Phase 1–4, including specialty therapeutics in immunology, dermatology, and rare disease.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Stable — net +4 jobs in 30d
39 added, 35 removed. Backfill posture.
Ergomed is a solid mid-market CRO for professionals seeking specialized PV/regulatory experience and hands-on client delivery, but limited public financials and modest pipeline activity require due diligence on job security and growth trajectory.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ergomed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ergomed's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles